ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2695

Latent Profile Analysis-Derived Typologies of Systemic Sclerosis Patients Using Body Image Indicators: A Scleroderma Patient-Centered Intervention Network (SPIN) Cohort Study

Shadi Gholizadeh1, Linda Kwakkenbos2, Marie-Eve Carrier3, Sarah D. Mills1, Rina S. Fox4, Lisa Jewett2, Karen Gottesman5, Scott Roesch1, Brett D. Thombs2 and Vanessa L. Malcarne1, 1SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, 2McGill University; Lady David Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada, 3McGill University, Montreal, QC, Canada, 4Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, 5Scleroderma Foundation, Los Angeles, CA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Body image, psychosocial, scleroderma and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: ARHP Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: A common and distressing manifestation of systemic sclerosis (SSc, or scleroderma) is disfigurement in socially relevant areas of the body, including the face and hands. Disease-related changes in appearance have been associated with body image dissatisfaction and social anxiety. Although there have been studies identifying correlates of body image dissatisfaction, there is a need for an examination that considers the complex relationships among the personal and social aspects of appearance changes. The present study used latent profile analysis (LPA) to identify body image typologies based on variables representing body image and social anxiety. Identified groups were compared on key sociodemographic, medical, and psychosocial variables.

Methods: The sample consisted of 942 patients with physician-confirmed SSc enrolled in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort who completed study questionnaires from April 2014 through October 2016. Patients in the SPIN Cohort were enrolled at 28 centers from Canada, the United States, and the United Kingdom. The sample was randomized into two groups (Sample 1: N = 469; Sample 2: N = 473) in order to conduct the analysis and provide an opportunity to replicate the findings. For the first aim, exploratory LPA was used to derive categorical latent variables that signified profiles of similarly scoring individuals using three indicators of subjective body image (i.e., dissatisfaction with appearance, social discomfort, and body concealment) and three indicators of social anxiety (i.e., social interaction anxiety, social appearance, anxiety, and fear of negative evaluation). For the second aim, differences in groups derived from the LPA were examined for select sociodemographic, medical, and psychosocial variables.

Results: The combined samples were predominantly female (87.4%) and White (79.8%), with limited disease (59%) and an average age of 55 years. In both samples, a two-profile solution was derived. These two classes were substantively analyzed for patterns of scores and termed the Appearance Comfortable (n = 336 and n = 375 in Samples 1 and 2, respectively) and Appearance Distressed (n = 133 and n = 98 in Samples 1 and 2, respectively) groups. In both samples, younger age, diffuse disease subtype, and the presence of hypo/hyper-pigmentation were associated with membership in the Appearance Distressed group. The mean modified Rodnan skin scores for patients in the Appearance Comfortable groups were 7.05 (SD = 7.3) and 7.67 (SD = 8.3) in Samples 1 and 2, respectively. The mean modified Rodnan skin scores for patients in the Appearance Distressed groups were 9.83 (SD = 9.6) and 9.60 (SD = 9.7), in Samples 1 and 2 respectively. Additionally, patients in the Appearance Distressed group had significantly higher scores on measures of depressive and anxious symptoms and disability.

Conclusion: This analysis was the first study to identify typologies of patients based on indicators of body image in any disfiguring condition. Two distinct groups were identified distinguishing between an Appearance Comfortable group and an Appearance Distressed group. The results also elucidated variables that can indicate likely group membership.


Disclosure: S. Gholizadeh, None; L. Kwakkenbos, None; M. E. Carrier, None; S. D. Mills, None; R. S. Fox, None; L. Jewett, None; K. Gottesman, None; S. Roesch, None; B. D. Thombs, None; V. L. Malcarne, None.

To cite this abstract in AMA style:

Gholizadeh S, Kwakkenbos L, Carrier ME, Mills SD, Fox RS, Jewett L, Gottesman K, Roesch S, Thombs BD, Malcarne VL. Latent Profile Analysis-Derived Typologies of Systemic Sclerosis Patients Using Body Image Indicators: A Scleroderma Patient-Centered Intervention Network (SPIN) Cohort Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/latent-profile-analysis-derived-typologies-of-systemic-sclerosis-patients-using-body-image-indicators-a-scleroderma-patient-centered-intervention-network-spin-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/latent-profile-analysis-derived-typologies-of-systemic-sclerosis-patients-using-body-image-indicators-a-scleroderma-patient-centered-intervention-network-spin-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology